David J. Flavell

1.6k total citations
56 papers, 1.3k citations indexed

About

David J. Flavell is a scholar working on Immunology, Molecular Biology and Biotechnology. According to data from OpenAlex, David J. Flavell has authored 56 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Immunology, 17 papers in Molecular Biology and 16 papers in Biotechnology. Recurrent topics in David J. Flavell's work include Toxin Mechanisms and Immunotoxins (29 papers), Transgenic Plants and Applications (15 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). David J. Flavell is often cited by papers focused on Toxin Mechanisms and Immunotoxins (29 papers), Transgenic Plants and Applications (15 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). David J. Flavell collaborates with scholars based in United Kingdom, Italy and Germany. David J. Flavell's co-authors include David B. Jones, Daniel Wright, Rodolfo Ippoliti, P Brandtzæg, Magne K. Fagerhol, Sebastian Lucas, Maria Serena Fabbrini, Francesco Giansanti, Deborah A. Boehm and Sue Lucas and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and The FASEB Journal.

In The Last Decade

David J. Flavell

56 papers receiving 1.3k citations

Peers

Countries citing papers authored by David J. Flavell

Since Specialization

Citations

This map shows the geographic impact of David J. Flavell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Flavell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Flavell more than expected).

Fields of papers citing papers by David J. Flavell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Flavell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Flavell. The network helps show where David J. Flavell may publish in the future.

Co-authorship network of co-authors of David J. Flavell

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Flavell. A scholar is included among the top collaborators of David J. Flavell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Flavell. David J. Flavell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antibody-Drug Conjugates: The New Frontier of Chemotherapy 2020 ·International Journal of Molecular Sciences ·(unknown), (unknown), Giuseppina Pitari, Annamaria Cimini, Matteo Ardini, Roberta Gentile, Stefano Iacobelli, Gianluca Sala, Emily Capone, David J. Flavell, Rodolfo Ippoliti, Francesco Giansanti	125
2	Membrane cholesterol is essential for triterpenoid saponin augmentation of a saporin-based immunotoxin directed against CD19 on human lymphoma cells 2017 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Wendy S. Smith, Ella J. Baker, (unknown), Grielof Koster, Alan N. Hunt, David A. Johnston, (unknown), David J. Flavell	16
3	Systematic comparison of single-chain Fv antibody-fusion toxin constructs containing Pseudomonas Exotoxin A or saporin produced in different microbial expression systems 2015 ·Microbial Cell Factories ·(unknown), (unknown), Alessio Lombardi, (unknown), Giovanni Tagliabue, Aldo Ceriotti, (unknown), (unknown), Francesco Giansanti, Riccardo Vago, Rodolfo Ippoliti, (unknown), David J. Flavell, Marco Colombatti, Maria Serena Fabbrini	20
4	Triterpenoid saponin augmention of saporin-based immunotoxin cytotoxicity for human leukaemia and lymphoma cells is partially immunospecific and target molecule dependent 2014 ·Immunopharmacology and Immunotoxicology ·(unknown), Christopher Bachran, Hendrik Fuchs, Alexander Weng, Matthias F. Melzig, (unknown), David J. Flavell	23
5	Engineering a switchable toxin: the potential use of PDZ domains in the expression, targeting and activation of modified saporin variants 2009 ·Protein Engineering Design and Selection ·Francesco Giansanti, (unknown), (unknown), Giuseppina Pitari, Maria Serena Fabbrini, Alessio Lombardi, David J. Flavell, (unknown), Stefano Gianni, Rodolfo Ippoliti	9
6	Stimulation of antibody dependent cellular cytotoxicity (ADCC) in SCID mice significantly improves the therapeutic efficacy of an anti-CD7 antibody and immunotoxin directed against human T-cell leukaemia xenografts 2005 ·Cancer Research ·David J. Flavell, (unknown), Sarah L. Warnes, (unknown), (unknown)	1
7	Saporin and ricin A chain follow different intracellular routes to enter the cytosol of intoxicated cells 2005 ·FEBS Journal ·Riccardo Vago, Catherine J. Marsden, Janet M. Lord, Rodolfo Ippoliti, David J. Flavell, (unknown), Aldo Ceriotti, Maria Serena Fabbrini	68
8	Comparison of Immunotoxins Bearing a Single Saporin Molecule with Multiple Toxin Conjugates 2003 ·Humana Press eBooks ·David J. Flavell, (unknown)	1
9	Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin 2001 ·British Journal of Cancer ·David J. Flavell, Deborah A. Boehm, (unknown), Sarah L. Warnes, (unknown)	30
10	Saporin Immunotoxins 1998 ·Current topics in microbiology and immunology ·David J. Flavell	20
11	MODELLING HUMAN LEUKEMIA AND LYMPHOMA IN SEVERE COMBINED IMMUNODEFICIENT (SCID) MICE: PRACTICAL APPLICATIONS 1996 ·Hematological Oncology ·David J. Flavell	10
12	Comparison of the therapeutic efficacy of anti-CD7-saporin immunotoxins constructed with one or two saporin moieties per immunotoxin molecule in SCID mice with human T-cell acute leukaemia 1995 ·David J. Flavell, Deborah A. Boehm, (unknown), (unknown), (unknown)	1
13	Therapy of human B‐cell lymphoma bearing scid mice is more effective with anti‐CD19‐and anti‐CD38‐saporin immunotoxins used in combination than with either immunotoxin used alone 1995 ·International Journal of Cancer ·David J. Flavell, Deborah A. Boehm, (unknown), (unknown), Alan G. Ramsay, (unknown)	28
14	Comparison of the performance of anti‐CD7 and anti‐CD38 bispecific antibodies and immunotoxins for the delivery of saporin to a human T‐cell acute lymphoblastic leukemia cell line 1995 ·Hematological Oncology ·David J. Flavell, (unknown), (unknown), (unknown), (unknown)	11
15	Glycosylation patterns of the human colon cancer cell line HT-29 detected byHelix pomatia agglutinin and other lectins in culture, in primary tumours and in metastases in SCID mice 1994 ·Clinical & Experimental Metastasis ·Udo Schumacher, Elizabeth Adam, David J. Flavell, Deborah A. Boehm, Susan A. Brooks, Anthony J. Leathem	28
16	Effectiveness of HB2 (anti-CD7) – saporin immunotoxin in an in vivo model of human T-cell leukaemia developed in severe combined immunodeficient mice 1994 ·British Journal of Cancer ·Bruce Morland, (unknown), Deborah A. Boehm, (unknown), (unknown), J A Kohler, (unknown), Bridget S. Wilkins, David J. Flavell	22
17	High‐dose mitoxantrone and etoposide conditioning in autologous bone marrow transplantation for relapsed Hodgkin's disease 1992 ·European Journal Of Haematology ·S. H. Lim, Trevor Baglin, David J. Flavell, (unknown), J. Z. Wimperis, Robert Marcus	4
18	Identification of peanut agglutinin binding glycoproteins restricted to Hodgkin's disease‐derived cell lines 1989 ·Hematological Oncology ·David J. Flavell, David B. Jones, Daniel Wright	7
19	Development of a sensitive monoclonal antibody-based enzyme-linked immunosorbent assay (ELISA) for mitozantrone 1988 ·Journal of Immunological Methods ·(unknown), David J. Flavell	16
20	Promotion of N-nitrosodimethylamine-initiated bile duct carcinogenesis in the hamster by the human liver fluke, Opisthorch is viverrini 1983 ·Carcinogenesis ·David J. Flavell, Sebastian Lucas	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact